Biora Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018
Market Capitalization	24	32	25	342	249	-	-
Market Cap Growth	-	27.60%	-92.67%	37.20%	-	-	-
Enterprise Value	54	63	122	380	318	40	4
PE Ratio	-0.26	-0.26	-0.66	-1.38	-1.29	-	-
PS Ratio	5759.35	7999.99	82.22	274.45	1539.78	-	-
PB Ratio	-0.32	-0.32	-0.24	-4.03	-2.33	-	-
P/FCF Ratio	-0.66	-0.66	-0.38	-2.03	-1.47	-	-
P/OCF Ratio	-0.66	-0.66	-0.39	-2.04	-1.50	-	-
EV/Sales Ratio	13384.60	15625.24	401.32	304.93	1962.40	0.28	0.03
EV/EBITDA Ratio	-0.55	-0.55	-4.59	-1.63	-1.45	-0.30	-0.03
EV/EBIT Ratio	-0.55	-0.55	-4.44	-1.62	-1.44	-0.29	-0.03
EV/FCF Ratio	-1.29	-1.29	-1.88	-2.26	-1.87	-0.37	-0.05
Debt / Equity Ratio	-0.45	-0.45	-1.25	-1.49	-1.50	-0.87	-1.97
Debt / EBITDA Ratio	-0.40	-0.40	-4.79	-0.54	-0.73	-0.54	-0.67
Debt / FCF Ratio	-0.94	-0.94	-1.96	-0.75	-0.95	-0.67	-1.04
Quick Ratio	0.24	0.24	1.31	1.45	1.36	0.55	0.91
Current Ratio	0.30	0.30	1.64	1.60	1.74	0.74	1.14
Asset Turnover	0	0	0.00	0.01	0.00	1.32	-
Interest Coverage	-11.65	-11.65	-2.51	-18.59	-22.20	-15.17	-12.62
Return on Equity (ROE)	111.30%	111.30%	39.20%	187.80%	286.30%	378.70%	-
Return on Assets (ROA)	-294.10%	-294.10%	-54.50%	-217.50%	-135.00%	-209.80%	-
Return on Capital (ROIC)	120.52%	120.52%	-242.05%	-284.44%	-200.98%	1334.34%	-319.38%
Earnings Yield	-538.75%	-387.86%	-152.16%	-72.29%	-77.29%	-	-
FCF Yield	-210.92%	-151.85%	-260.03%	-49.19%	-68.00%	-	-
Buyback Yield / Dilution	-106.59%	-106.59%	-98.51%	-249.49%	-463.48%	-4.84%	-
Total Shareholder Return	-106.59%	-106.59%	-98.51%	-249.49%	-463.48%	-4.84%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).